Finance

Lists
THC:NYSE
Tenet Healthcare Corp
290,33 US$
+1,50%
(+4,30) 1D
16 ნოე, 13:36:19 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for THC...
Open
290,00 US$
High
295,97 US$
Low
289,88 US$
Mkt. cap
23,11 მლრდ.
Avg. vol.
800,47 ათ.
Volume
227,08 ათ.
P/E ratio
8,42
52-wk high
295,97 US$
52-wk low
157,58 US$
EPS
34,48 US$
Beta
1,20
Shares outstanding
79,59 მლნ.
No. of employees
88 ათ.
Open
290,00 US$
High
295,97 US$
Low
289,88 US$
Mkt. cap
23,11 მლრდ.
Avg. vol.
800,47 ათ.
Volume
227,08 ათ.
P/E ratio
8,42
52-wk high
295,97 US$
52-wk low
157,58 US$
EPS
34,48 US$
Beta
1,20
Shares outstanding
79,59 მლნ.
No. of employees
88 ათ.
News stories
From web sources and news partners
Profile
Tenet Healthcare Corporation is an American for-profit multinational healthcare services company based in Dallas. Through its brands, subsidiaries, joint ventures, and partnerships including United Surgical Partners International, the company operates around 65 hospitals and over 450 healthcare facilities. Tenet also runs Conifer Health Solutions, which provides healthcare support services to health systems and other clients. Since its founding in 1969, Tenet has expanded significantly. Among other major acquisitions and formations, Tenet founded Conifer Health Solutions in 2008, MedPost Urgent Care in 2014, and in 2013 acquired Vanguard Health Systems, Inc., an investor-owned hospital company whose operations complemented Tenet's existing business. The acquisition created the third-largest investor-owned hospital company in the United States in terms of revenue and the third-largest in number of hospitals owned. In 2015, Tenet acquired USPI, which created the largest operator of outpatient surgery centers in the U.S. In 2021, the company ranked 167th in the Fortune 500. Wikipedia
About Tenet Healthcare Corp
CEOსაუმ სუტარია
Employees88,5 ათ.
Founded1969
Headquartersდალასი, ტეხასი, ამერიკის შეერთებული შტატები
SectorHealth Care
IndustryHealth care provider
Analyst ratings
Based on 16 analysts giving stock ratings to THC in the past 3 months
Strong buy
Buy
14
Hold
2
Sell
0
12-month forecast
Based on 16 Wall Street analysts offering 12 month price targets for THC in the last 3 months.
Highest
Current 290,33 US$
342,00 US$ (+17,80%)
Average
308,27 US$ (+6,18%)
Lowest
265,00 US$ (-8,72%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ann Hynes
Mizuho Securities
Buy
Maintained
330,00 US$
+13,7%
11/15/2026
Scott Fidel
Goldman Sachs
Buy
Maintained
320,00 US$
+10,2%
11/10/2026
Kevin Fischbeck
Bank of America Securities
Buy
Maintained
-
-
11/05/2026
Andrew Mok CFA
Barclays
Buy
Maintained
297,00 US$
+2,3%
11/04/2026
Matthew Gillmor CFA
KeyBanc
Buy
Maintained
300,00 US$
+3,3%
11/03/2026
Whit Mayo
Leerink Partners
Buy
Reiterated
342,00 US$
+17,8%
11/02/2026
A.J. Rice
UBS
Buy
Maintained
340,00 US$
+17,1%
11/02/2026
Ben Hendrix
RBC Capital
Buy
Reiterated
304,00 US$
+4,7%
11/01/2026
Ryan Langston
TD Cowen
Buy
Maintained
302,00 US$
+4%
11/02/2026
Stephen Baxter
Wells Fargo
Buy
Maintained
321,00 US$
+10,6%
11/02/2026
John Ransom
Raymond James
Buy
Maintained
300,00 US$
+3,3%
10/30/2026
Craig Hettenbach
Morgan Stanley
Buy
Reiterated
297,00 US$
+2,3%
10/30/2026
Sean Dodge
BMO Capital
Hold
Reiterated
265,00 US$
-8,7%
10/29/2026
Jason Cassorla
Guggenheim
Buy
Maintained
306,00 US$
+5,4%
10/29/2026
Michael Ha
Robert W. Baird
Hold
Maintained
285,00 US$
-1,8%
10/30/2026
Andrew Cooper
Raymond James
Buy
Reiterated
285,00 US$
-1,8%
09/28/2026
Benjamin Rossi
J.P. Morgan
Buy
Maintained
315,00 US$
+8,5%
09/01/2026
Unknown Analyst
Stephens
Buy
Maintained
285,00 US$
-1,8%
07/27/2026
Raj Kumar CFA
Stephens
Buy
Maintained
285,00 US$
-1,8%
07/27/2026
David S Macdonald
Truist Financial
Buy
Reiterated
290,00 US$
-0,1%
07/28/2026
Sarah James
Cantor Fitzgerald
Buy
Maintained
245,00 US$
-15,6%
07/23/2026
Last report
29 ოქტ. 2026
Fiscal period
Q3 2026
6,64 US$ / 4,68 US$
+42,01%beat
Revenue / Est. (USD)
5,63 მლრდ. / 5,51 მლრდ.
+2,19%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
დეკ. 2025
მარ. 2026
ივნ. 2026
სექ. 2026
Revenue
5,53 მლრდ.
5,37 მლრდ.
5,63 მლრდ.
5,63 მლრდ.
Cost of goods sold
3,23 მლრდ.
3,14 მლრდ.
3,22 მლრდ.
3,16 მლრდ.
Cost of revenue
3,23 მლრდ.
3,14 მლრდ.
3,22 მლრდ.
3,16 მლრდ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
410,00 მლნ.
102,00 მლნ.
104,00 მლნ.
105,00 მლნ.
Operating expense
1,33 მლრდ.
1,27 მლრდ.
1,39 მლრდ.
1,40 მლრდ.
Total operating expenses
4,56 მლრდ.
4,40 მლრდ.
4,61 მლრდ.
4,56 მლრდ.
Operating income
965,00 მლნ.
963,00 მლნ.
1,02 მლრდ.
1,07 მლრდ.
Other non operating income
39,00 მლნ.
43,00 მლნ.
45,00 მლნ.
39,00 მლნ.
EBT including unusual items
681,00 მლნ.
1,13 მლრდ.
1,34 მლრდ.
1,58 მლრდ.
EBT excluding unusual items
882,00 მლნ.
852,00 მლნ.
928,00 მლნ.
972,00 მლნ.
Income tax expense
37,00 მლნ.
226,00 მლნ.
295,00 მლნ.
360,00 მლნ.
Effective tax rate
5,43%
19,96%
22,01%
22,80%
Other operating expenses
687,00 მლნ.
937,00 მლნ.
1,07 მლრდ.
1,08 მლრდ.
Net income
371,00 მლნ.
702,00 მლნ.
826,00 მლნ.
1,00 მლრდ.
Net profit margin
6,71%
13,08%
14,68%
17,76%
Earnings per share
4,70
4,82
6,12
6,64
Interest and investment income
-
-
-
-
Interest expense
-205,00 მლნ.
-205,00 მლნ.
-204,00 მლნ.
-203,00 მლნ.
Net interest expenses
-205,00 მლნ.
-205,00 მლნ.
-204,00 მლნ.
-203,00 მლნ.
Depreciation and amortization charges
231,00 მლნ.
229,00 მლნ.
215,00 მლნ.
217,00 მლნ.
EBITDA
1,20 მლრდ.
1,19 მლრდ.
1,24 მლრდ.
1,29 მლრდ.
Gain or loss from assets sale
5,00 მლნ.
-1,00 მლნ.
-33,00 მლნ.
-9,00 მლნ.
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google აპები